1Tomlinson GE,Finegold MJ.Liver tumors.In:Pizzo PA,Poplack DG.Principles and Practice of Pediatric Oncology,4 th ed.Philadelphia:Lippincott Williams & Wilkins,2002:847-865.
3Harada K,Toyooka S,Maitra A,et al.Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.Oncogene,2002,21:4345-4349.
4Shim YH,Park HJ,Choi MS,et al.Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.Mod Pathol,2003,16:430-436.
5Nagai H,Naka T,Terada Y,et al.Hypermethylation associated with inactivation of the SOCS-1 gene,a JAK/STAT inhibitor,in human hepatoblastomas.J Hum Genet,2003,48:65-69.
6McLaughlin CC,Baptiste MS,Schymura MJ,et al.Maternal and infant birth characteristics and hepatoblastoma.Am J Epidemiol,2006,163:818-828.
2[1]Tomlinson GE,Finegold MJ.Tumors of the liver.Pizzo PA,Poplack DG,editors.Principles and practice of pediatric oncology[J].Philadelphia:Lippincott williamsand Wklkins,2002,847-864.
3[2]Ingram JD,Yemshalmi B,Connell J,et al.Hepatoblastoma in a neonate:a hypervascular presentation mimicking hemangioendothe-lioma[J].Pediatr Radiol,2000,30:794-797.
4[3]Hart Isaacs Jr.Fetal and neonatal hepatic tumors[J]J Pediatr Surg,2007,42:1797-1803.
5[4]Davies JQ,de la Hall PM,Kaschula RQ,et al:Hepatoblastoma-evolution of management and outcome and significance of histology of the resected tumor.A 31-year experience with 40 cases[J].J Pediatr Surg,2004,39(9):1321-1327.
6[5]Reynolds P,Umyama KY,Von Behren J,et al.(2004) Birth haracteristics and hepatoblastoma risk in young children[J].Cancer,100,1070-1076.
